Literature DB >> 16207733

Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome.

Molly B Sheridan1, Peying Fong, Joshua D Groman, Carol Conrad, Patrick Flume, Ruben Diaz, Christopher Harris, Michael Knowles, Garry R Cutting.   

Abstract

Cystic fibrosis (CF) is an autosomal recessive disorder of Cl(-) and Na(+) transport. The vast majority of CF patients have deleterious mutations in an epithelial Cl(-) channel called the CF transmembrane conductance regulator (CFTR). In contrast, defects in the epithelial Na(+) channel (SCNN1) have been associated with phenotypes dominated by renal disease (systemic pseudohypoaldosteronism type I and Liddle syndrome). We report two non-classic CF patients without CFTR mutations who have novel deleterious mutations in the beta-subunits of SCNN1 in the absence of overt renal disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207733     DOI: 10.1093/hmg/ddi374

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  23 in total

1.  Nadph oxidase regulates alveolar epithelial sodium channel activity and lung fluid balance in vivo via O⁻₂ signaling.

Authors:  Preston Goodson; Amrita Kumar; Lucky Jain; Kousik Kundu; Niren Murthy; Michael Koval; My N Helms
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-09       Impact factor: 5.464

Review 2.  ENaCs and ASICs as therapeutic targets.

Authors:  Yawar J Qadri; Arun K Rooj; Catherine M Fuller
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

3.  Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders--updated European recommendations.

Authors:  Els Dequeker; Manfred Stuhrmann; Michael A Morris; Teresa Casals; Carlo Castellani; Mireille Claustres; Harry Cuppens; Marie des Georges; Claude Ferec; Milan Macek; Pier-Franco Pignatti; Hans Scheffer; Marianne Schwartz; Michal Witt; Martin Schwarz; Emmanuelle Girodon
Journal:  Eur J Hum Genet       Date:  2008-08-06       Impact factor: 4.246

4.  Loss of carbonic anhydrase XII function in individuals with elevated sweat chloride concentration and pulmonary airway disease.

Authors:  Melissa Lee; Briana Vecchio-Pagán; Neeraj Sharma; Abdul Waheed; Xiaopeng Li; Karen S Raraigh; Sarah Robbins; Sangwoo T Han; Arianna L Franca; Matthew J Pellicore; Taylor A Evans; Kristin M Arcara; Hien Nguyen; Shan Luan; Deborah Belchis; Jozef Hertecant; Joseph Zabner; William S Sly; Garry R Cutting
Journal:  Hum Mol Genet       Date:  2016-02-23       Impact factor: 6.150

5.  Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease.

Authors:  Eva P Szymanski; Janice M Leung; Cedar J Fowler; Carissa Haney; Amy P Hsu; Fei Chen; Priya Duggal; Andrew J Oler; Ryan McCormack; Eckhard Podack; Rebecca A Drummond; Michail S Lionakis; Sarah K Browne; D Rebecca Prevots; Michael Knowles; Gary Cutting; Xinyue Liu; Scott E Devine; Claire M Fraser; Hervé Tettelin; Kenneth N Olivier; Steven M Holland
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

6.  Gain-of-function variant of the human epithelial sodium channel.

Authors:  Jingxin Chen; Thomas R Kleyman; Shaohu Sheng
Journal:  Am J Physiol Renal Physiol       Date:  2012-11-07

7.  Novel mutation in the epithelial sodium channel causing type I pseudohypoaldosteronism in a patient misdiagnosed with cystic fibrosis.

Authors:  Francisco Mora-Lopez; Manuel Bernal-Quiros; Alfonso M Lechuga-Sancho; Jose Luis Lechuga-Campoy; Nestor Hernandez-Trujillo; Antonio Nieto
Journal:  Eur J Pediatr       Date:  2012-02-28       Impact factor: 3.183

8.  Whole-gene CFTR sequencing combined with digital RT-PCR improves genetic diagnosis of cystic fibrosis.

Authors:  Letizia Straniero; Giulia Soldà; Lucy Costantino; Manuela Seia; Paola Melotti; Carla Colombo; Rosanna Asselta; Stefano Duga
Journal:  J Hum Genet       Date:  2016-08-04       Impact factor: 3.172

Review 9.  Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

Authors:  C Castellani; H Cuppens; M Macek; J J Cassiman; E Kerem; P Durie; E Tullis; B M Assael; C Bombieri; A Brown; T Casals; M Claustres; G R Cutting; E Dequeker; J Dodge; I Doull; P Farrell; C Ferec; E Girodon; M Johannesson; B Kerem; M Knowles; A Munck; P F Pignatti; D Radojkovic; P Rizzotti; M Schwarz; M Stuhrmann; M Tzetis; J Zielenski; J S Elborn
Journal:  J Cyst Fibros       Date:  2008-05       Impact factor: 5.482

Review 10.  The cystic fibrosis gene: a molecular genetic perspective.

Authors:  Lap-Chee Tsui; Ruslan Dorfman
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.